Expression of Concern: BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines

被引：0
|
作者：
M. Cuadros
V. Sánchez-Martín
A. Herrera-Merchan
C. Baliñas
J. Martín-Padrón
L. Boyero
P. Peinado
P. P. Medina
机构：
[1] University of Granada,Department of Biochemistry and Molecular Biology III and Immunology
[2] GENYO,Department of Biochemistry and Molecular Biology I
[3] Centre for Genomics and Oncological Research,undefined
[4] University of Granada,undefined
来源：
Clinical and Translational Oncology | 2019年 / 21卷 / 11期
关键词：
D O I：
10.1007/s12094-019-02178-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1581 / 1581
相关论文
共 50 条
  • [11] Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis
    Zheng, Shu-Rong
    Guo, Gui-Long
    Zhang, Wei
    Huang, Guan-Li
    Hu, Xiao-Qu
    Zhu, Jin
    Huang, Qi-Di
    You, Jie
    Zhang, Xiao-Hua
    ONCOLOGY REPORTS, 2012, 27 (04) : 1149 - 1155
  • [12] BRG1 expression is increased in human cutaneous melanoma
    Lin, H.
    Wong, R. P. C.
    Martinka, M.
    Li, G.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (03) : 502 - 510
  • [13] Influence of Adriamycin and Wogonin on the Expression of Mir-155 in Burrkit Lymphoma in Vitro
    Wu, Xue
    Wang, Fei
    Xia, Guohua
    Chen, Yanping
    Chen, Baoan
    BLOOD, 2014, 124 (21)
  • [14] Phase 1 Trial of Cobomarsen, an Inhibitor of Mir-155, in Cutaneous T Cell Lymphoma
    Querfeld, Christiane
    Foss, Francine M.
    Kim, Youn H.
    Pinter-Brown, Lauren
    William, Basem M.
    Porcu, Pierluigi
    Pacheco, Theresa
    Haverkos, Bradley M.
    DeSimone, Jennifer
    Guitart, Joan
    Halwani, Ahmad S.
    Eradat, Herbert A.
    Huen, Auris
    Schroeder, Kristin
    Pestano, Linda A.
    Williams, Paul J., Jr.
    Cheronis, Ioanna
    Gordon, Gilad S.
    Escolar, Diana
    Rubin, Paul
    Marshall, William S.
    BLOOD, 2018, 132
  • [15] LOW EXPRESSION OF MIR-155 IN VINCRISTINE RESISTANT DIFFUSE LARGE B-CELL LYMPHOMA
    Due, H.
    Schonherz, A. Amanda
    Krogh, L. Bechmann
    Bodker, J. Stove
    Schmitz, A.
    Brondum, R. Froberg
    Johnsen, H. Erik
    Bogsted, M.
    Mikkelsen, J. Giehm
    Roug, A. Stidsholt
    Dybkaer, K.
    HAEMATOLOGICA, 2016, 101 : 398 - 398
  • [16] A Feedback Loop between MicroRNA 155 (miR-155), Programmed Cell Death 4, and Activation Protein 1 Modulates the Expression of miR-155 and Tumorigenesis in Tongue Cancer
    Zargar, Shabir
    Tomar, Vivek
    Shyamsundar, Vidyarani
    Vijayalakshmi, Ramshankar
    Somasundaram, Kumaravel
    Karunagaran, Devarajan
    MOLECULAR AND CELLULAR BIOLOGY, 2019, 39 (06)
  • [17] Regulated expression of miR-155 is required for iNKT cell development
    Burocchi, Alessia
    Pittoni, Paola
    Tili, Esmerina
    Rigoni, Alice
    Costinean, Stefan
    Croce, Carlo Maria
    Colombo, Mario Paolo
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [18] Identification of miR-155 targets to elucidate the role of high miR-155 levels in B cell Hodgkin and non-Hodgkin lymphoma
    Gibcus, J.
    Schakel, R. N.
    Harms, G.
    Kluiver, J.
    Tan, L. P.
    Popperna, S.
    Kroesen, B. J.
    Van den Berg, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 39 - 39
  • [19] The effects of cellular context on miR-155 mediated regulation of gene expression
    Hsin, Jing-Ping
    Lu, Yuheng
    Leslie, Christina S.
    Rudensky, Alexander Y.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [20] Subtype specific expression of immnune-modulating miR-155 and miR-146a in anaplastic large cell lymphoma
    Merkel, Olaf
    Griessl, Robert
    Hamacherl, Frank
    Grabner, Lisa M.
    Greil, Richard
    Kenner, Lukas
    CANCER RESEARCH, 2012, 72
12345